Dulonor-P Tablet
Marketer
Doxis Laboratories
Salt Composition
Propranolol (40mg) + Flunarizine (5mg)
Overview Dulonor-P Tablet
Migravent Duo tablets combine two active ingredients to prevent migraine episodes. This medication is not for treating migraines already in progress. Migravent Duo should be taken on an empty stomach, consistently at the same time each day, ideally at night. Dosage and frequency depend on individual needs, determined by your physician to optimize symptom management. Continue taking this medication as prescribed. Lifestyle adjustments, such as stress reduction, smoking cessation, and limiting processed foods, may enhance its effectiveness. Common side effects include weight increase, bradycardia, fatigue, depression, somnolence, and cold extremities. Drowsiness may occur; avoid driving or activities requiring alertness, and rise slowly from a seated position. This drug can mask hypoglycemia; therefore, regularly monitor blood glucose and blood pressure during treatment. Inform your doctor of any pre-existing liver or kidney disease, depression, or pregnancy/breastfeeding before commencing treatment. Also disclose all other medications you are taking, as interactions may reduce efficacy or alter the medication's action.
Uses of Dulonor-P Tablet
Migraine Prevention Strategies
Major Benefits of Dulonor-P Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Dulonor-P Tablet on an empty stomach.
Common Side effects of Dulonor-P Tablet:
- Weight gain
- Slow heart rate
- Tiredness
- Depression
- Drowsiness
- Abnormal dreams
- Cold extremities
How to use Dulonor-P Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dulonor-P Tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.
How Dulonor-P Tablet works:
Dulonor-P tablets combine propranolol, a beta-blocker, and flunarizine, a calcium channel blocker, to prevent migraine attacks. This synergistic action stabilizes overactive nerve cells, raising the threshold for migraine initiation. Additionally, the combination suppresses cortical spreading depression, the electrical brainwave activity responsible for migraine pain and inflammation.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Dulonor-P tablets.
PregnancyCONSULT YOUR DOCTOR
The use of Dulonor-P Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Dulonor-P Tablet use while breastfeeding is absent. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Dulonor-P Tablet side effects. These potential side effects include visual disturbances, hallucinations, fatigue, cognitive impairment, dizziness, and drowsiness.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can likely use Dulonor-P tablets without safety concerns. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should exercise caution when using Dulonor-P Tablets, as dose modification may be necessary. Physician consultation is recommended. Routine blood pressure monitoring is advised to guide appropriate dosage.
What if you forget to take Dulonor-P Tablet :
Should you forget a Dulonor-P Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dulonor-P Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
3,018 People bought this recently